Mechanisms of MHC class I–restricted antigen processing
E Pamer, P Cresswell - Annual review of immunology, 1998 - annualreviews.org
▪ Abstract Classical class I molecules assemble in the endoplasmic reticulum (ER) with
peptides mostly generated from cytosolic proteins by the proteasome. The activity of the …
peptides mostly generated from cytosolic proteins by the proteasome. The activity of the …
Broadly targeted CD8+ T cell responses restricted by major histocompatibility complex E
SG Hansen, HL Wu, BJ Burwitz, CM Hughes… - Science, 2016 - science.org
Major histocompatibility complex E (MHC-E) is a highly conserved, ubiquitously expressed,
nonclassical MHC class Ib molecule with limited polymorphism that is primarily involved in …
nonclassical MHC class Ib molecule with limited polymorphism that is primarily involved in …
A soluble single-chain T-cell receptor IL-2 fusion protein retains MHC-restricted peptide specificity and IL-2 bioactivity
KF Card, SA Price-Schiavi, B Liu, E Thomson… - Cancer Immunology …, 2004 - Springer
Antibody-based targeted immunotherapy has shown promise as an approach to treat
cancer. However, many known tumor-associated antigens are not expressed as integral …
cancer. However, many known tumor-associated antigens are not expressed as integral …
NetCTLpan: pan-specific MHC class I pathway epitope predictions
Reliable predictions of immunogenic peptides are essential in rational vaccine design and
can minimize the experimental effort needed to identify epitopes. In this work, we describe a …
can minimize the experimental effort needed to identify epitopes. In this work, we describe a …
Generation and TAP-mediated transport of peptides for major histocompatibility complex class I molecules
F Momburg, GJ Hämmerling - Advances in immunology, 1998 - Elsevier
Publisher Summary This chapter reviews the generation and TAP-mediated transport of
peptides for major histocompatibility complex class I molecules. The translocation of …
peptides for major histocompatibility complex class I molecules. The translocation of …
Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD
Skeletal muscle differentiation entails the coordination of muscle-specific gene expression
and terminal withdrawal from the cell cycle. This cell cycle arrest in the G0 phase requires …
and terminal withdrawal from the cell cycle. This cell cycle arrest in the G0 phase requires …
Roles for calreticulin and a novel glycoprotein, tapasin, in the interaction of MHC class I molecules with TAP
B Sadasivan, PJ Lehner, B Ortmann, T Spies… - Immunity, 1996 - cell.com
Assembly of MHC class I–β 2 microglobulin (β 2 m) dimers in the endoplasmic reticulum
involves two chaperones. Calnexin has previously been shown to interact with free class I …
involves two chaperones. Calnexin has previously been shown to interact with free class I …
Enhanced and prolonged cross‐presentation following endosomal escape of exogenous antigens encapsulated in biodegradable nanoparticles
H Shen, AL Ackerman, V Cody, A Giodini… - …, 2006 - Wiley Online Library
CD8+ T‐cell responses are critical in the immunological control of tumours and infectious
diseases. To prime CD8+ T cells against these cell‐associated antigens, exogenous …
diseases. To prime CD8+ T cells against these cell‐associated antigens, exogenous …
Generation of human cytotoxic T cells specific for human carcinoembryonic antigen epitopes from patients immunized with recombinant vaccinia-CEA vaccine
KY Tsang, S Zaremba, CA Nieroda… - JNCI: Journal of the …, 1995 - academic.oup.com
Background: The human carcinoembryonic antigen (CEA), which is expressed in several
cancer types, is a potential target for specific immunotherapy using recombinant vaccines …
cancer types, is a potential target for specific immunotherapy using recombinant vaccines …
Mesothelin-specific CD8+ T Cell Responses Provide Evidence of In Vivo Cross-Priming by Antigen-Presenting Cells in Vaccinated Pancreatic Cancer Patients
AM Thomas, LM Santarsiero, ER Lutz… - The Journal of …, 2004 - rupress.org
Tumor-specific CD8+ T cells can potentially be activated by two distinct mechanisms of
major histocompatibility complex class I–restricted antigen presentation as follows: direct …
major histocompatibility complex class I–restricted antigen presentation as follows: direct …